health
Weight-loss drugs can cut breast cancer risk by up to 30%, studies suggest
Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease
TL;DR
- GLP-1 weight-loss drugs may reduce the risk of developing or dying from cancer by up to 30%.
- One study found a 30% lower incidence of breast cancer in women taking GLP-1 medications.
- Adding weight-loss drugs to standard breast cancer treatment was associated with a 30% reduction in mortality risk.
- Patients with breast, lung, bowel, or liver cancer on weight-loss drugs were 38%-50% less likely to develop advanced stages of the disease.
- Researchers are exploring GLP-1 medications as potential cancer prevention tools due to their effects on inflammation, metabolism, and appetite regulation.
- The exact mechanisms by which these drugs impact cancer risk are still under investigation, with further studies needed to clarify their role beyond weight loss.
- Some patients on GLP-1 medications report an improvement in side effects from other cancer treatments, such as hormone blockers.